nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzatropine—CYP2C19—Gefitinib—lung cancer	0.125	0.23	CbGbCtD
Benzatropine—CYP2C19—Teniposide—lung cancer	0.121	0.223	CbGbCtD
Benzatropine—CYP2D6—Gefitinib—lung cancer	0.0947	0.175	CbGbCtD
Benzatropine—CYP2D6—Vinorelbine—lung cancer	0.0729	0.135	CbGbCtD
Benzatropine—CYP2D6—Erlotinib—lung cancer	0.056	0.103	CbGbCtD
Benzatropine—CYP2D6—Vinblastine—lung cancer	0.045	0.083	CbGbCtD
Benzatropine—CYP2D6—Doxorubicin—lung cancer	0.0276	0.051	CbGbCtD
Benzatropine—Appetite absent—Gefitinib—lung cancer	0.014	0.0498	CcSEcCtD
Benzatropine—Ileus paralytic—Vinblastine—lung cancer	0.00999	0.0356	CcSEcCtD
Benzatropine—Ileus paralytic—Vinorelbine—lung cancer	0.0083	0.0296	CcSEcCtD
Benzatropine—Trimethaphan—CHRNB4—lung cancer	0.00627	0.465	CrCbGaD
Benzatropine—Ileus—Vinblastine—lung cancer	0.0061	0.0218	CcSEcCtD
Benzatropine—Ileus—Erlotinib—lung cancer	0.00587	0.0209	CcSEcCtD
Benzatropine—Ileus paralytic—Paclitaxel—lung cancer	0.00558	0.0199	CcSEcCtD
Benzatropine—Cerebrovascular accident—Pemetrexed—lung cancer	0.00518	0.0185	CcSEcCtD
Benzatropine—Ileus—Vinorelbine—lung cancer	0.00507	0.0181	CcSEcCtD
Benzatropine—Dysphagia—Pemetrexed—lung cancer	0.00439	0.0156	CcSEcCtD
Benzatropine—Trimethaphan—CHRNA3—lung cancer	0.00434	0.322	CrCbGaD
Benzatropine—Ileus—Irinotecan—lung cancer	0.00418	0.0149	CcSEcCtD
Benzatropine—Hypoaesthesia—Crizotinib—lung cancer	0.00382	0.0136	CcSEcCtD
Benzatropine—Ileus—Paclitaxel—lung cancer	0.00341	0.0122	CcSEcCtD
Benzatropine—Cerebrovascular accident—Vinblastine—lung cancer	0.0032	0.0114	CcSEcCtD
Benzatropine—Vision blurred—Crizotinib—lung cancer	0.00315	0.0112	CcSEcCtD
Benzatropine—Cerebrovascular accident—Erlotinib—lung cancer	0.00308	0.011	CcSEcCtD
Benzatropine—Appetite absent—Methotrexate—lung cancer	0.00297	0.0106	CcSEcCtD
Benzatropine—Ileus—Docetaxel—lung cancer	0.00289	0.0103	CcSEcCtD
Benzatropine—Cerebrovascular accident—Vinorelbine—lung cancer	0.00266	0.00948	CcSEcCtD
Benzatropine—Dysphagia—Erlotinib—lung cancer	0.00261	0.00929	CcSEcCtD
Benzatropine—Dry mouth—Gefitinib—lung cancer	0.00253	0.00901	CcSEcCtD
Benzatropine—Decreased appetite—Crizotinib—lung cancer	0.00237	0.00846	CcSEcCtD
Benzatropine—Constipation—Crizotinib—lung cancer	0.00233	0.00832	CcSEcCtD
Benzatropine—Dysphagia—Vinorelbine—lung cancer	0.00225	0.00803	CcSEcCtD
Benzatropine—Cerebrovascular accident—Irinotecan—lung cancer	0.00219	0.00782	CcSEcCtD
Benzatropine—Decreased appetite—Pemetrexed—lung cancer	0.00217	0.00773	CcSEcCtD
Benzatropine—Hypoaesthesia—Vinblastine—lung cancer	0.00216	0.00769	CcSEcCtD
Benzatropine—Body temperature increased—Crizotinib—lung cancer	0.00216	0.00769	CcSEcCtD
Benzatropine—Decreased appetite—Gefitinib—lung cancer	0.00215	0.00768	CcSEcCtD
Benzatropine—Cerebrovascular accident—Gemcitabine—lung cancer	0.00214	0.00762	CcSEcCtD
Benzatropine—Constipation—Pemetrexed—lung cancer	0.00213	0.0076	CcSEcCtD
Benzatropine—Constipation—Gefitinib—lung cancer	0.00212	0.00755	CcSEcCtD
Benzatropine—Hypoaesthesia—Topotecan—lung cancer	0.0021	0.00748	CcSEcCtD
Benzatropine—Confusional state—Teniposide—lung cancer	0.00204	0.00726	CcSEcCtD
Benzatropine—Cerebrovascular accident—Cisplatin—lung cancer	0.00199	0.0071	CcSEcCtD
Benzatropine—Tachycardia—Teniposide—lung cancer	0.00197	0.00703	CcSEcCtD
Benzatropine—Body temperature increased—Pemetrexed—lung cancer	0.00197	0.00703	CcSEcCtD
Benzatropine—Body temperature increased—Gefitinib—lung cancer	0.00196	0.00698	CcSEcCtD
Benzatropine—Hypersensitivity—Pemetrexed—lung cancer	0.00184	0.00655	CcSEcCtD
Benzatropine—Hypersensitivity—Gefitinib—lung cancer	0.00183	0.00651	CcSEcCtD
Benzatropine—Ileus—Doxorubicin—lung cancer	0.0018	0.00643	CcSEcCtD
Benzatropine—Hypoaesthesia—Vinorelbine—lung cancer	0.00179	0.00639	CcSEcCtD
Benzatropine—Cerebrovascular accident—Paclitaxel—lung cancer	0.00179	0.00638	CcSEcCtD
Benzatropine—Decreased appetite—Teniposide—lung cancer	0.00176	0.00626	CcSEcCtD
Benzatropine—Vomiting—Crizotinib—lung cancer	0.00174	0.00619	CcSEcCtD
Benzatropine—Rash—Crizotinib—lung cancer	0.00172	0.00613	CcSEcCtD
Benzatropine—Dermatitis—Crizotinib—lung cancer	0.00172	0.00613	CcSEcCtD
Benzatropine—Feeling abnormal—Teniposide—lung cancer	0.00166	0.00593	CcSEcCtD
Benzatropine—Nausea—Crizotinib—lung cancer	0.00162	0.00578	CcSEcCtD
Benzatropine—Body temperature increased—Teniposide—lung cancer	0.0016	0.00569	CcSEcCtD
Benzatropine—Vomiting—Pemetrexed—lung cancer	0.00159	0.00565	CcSEcCtD
Benzatropine—Vomiting—Gefitinib—lung cancer	0.00158	0.00562	CcSEcCtD
Benzatropine—Rash—Pemetrexed—lung cancer	0.00157	0.00561	CcSEcCtD
Benzatropine—Dermatitis—Pemetrexed—lung cancer	0.00157	0.0056	CcSEcCtD
Benzatropine—Rash—Gefitinib—lung cancer	0.00156	0.00557	CcSEcCtD
Benzatropine—Dermatitis—Gefitinib—lung cancer	0.00156	0.00556	CcSEcCtD
Benzatropine—Dysphagia—Etoposide—lung cancer	0.00155	0.00551	CcSEcCtD
Benzatropine—Dysphagia—Paclitaxel—lung cancer	0.00152	0.0054	CcSEcCtD
Benzatropine—Hypersensitivity—Teniposide—lung cancer	0.00149	0.00531	CcSEcCtD
Benzatropine—Nausea—Pemetrexed—lung cancer	0.00148	0.00528	CcSEcCtD
Benzatropine—Nausea—Gefitinib—lung cancer	0.00147	0.00525	CcSEcCtD
Benzatropine—Dysuria—Paclitaxel—lung cancer	0.00142	0.00505	CcSEcCtD
Benzatropine—Decreased appetite—Vinblastine—lung cancer	0.00134	0.00478	CcSEcCtD
Benzatropine—Constipation—Vinblastine—lung cancer	0.00132	0.0047	CcSEcCtD
Benzatropine—Decreased appetite—Topotecan—lung cancer	0.0013	0.00464	CcSEcCtD
Benzatropine—Decreased appetite—Erlotinib—lung cancer	0.00129	0.00459	CcSEcCtD
Benzatropine—Vomiting—Teniposide—lung cancer	0.00128	0.00458	CcSEcCtD
Benzatropine—Dysphagia—Docetaxel—lung cancer	0.00128	0.00458	CcSEcCtD
Benzatropine—Constipation—Topotecan—lung cancer	0.00128	0.00456	CcSEcCtD
Benzatropine—Rash—Teniposide—lung cancer	0.00127	0.00454	CcSEcCtD
Benzatropine—Dermatitis—Teniposide—lung cancer	0.00127	0.00454	CcSEcCtD
Benzatropine—Feeling abnormal—Vinblastine—lung cancer	0.00127	0.00453	CcSEcCtD
Benzatropine—Constipation—Erlotinib—lung cancer	0.00127	0.00452	CcSEcCtD
Benzatropine—Tachycardia—Vinorelbine—lung cancer	0.00125	0.00446	CcSEcCtD
Benzatropine—Feeling abnormal—Topotecan—lung cancer	0.00123	0.0044	CcSEcCtD
Benzatropine—Hypoaesthesia—Etoposide—lung cancer	0.00123	0.00439	CcSEcCtD
Benzatropine—Hypoaesthesia—Paclitaxel—lung cancer	0.00121	0.0043	CcSEcCtD
Benzatropine—Nausea—Teniposide—lung cancer	0.0012	0.00428	CcSEcCtD
Benzatropine—Body temperature increased—Topotecan—lung cancer	0.00118	0.00422	CcSEcCtD
Benzatropine—Body temperature increased—Erlotinib—lung cancer	0.00117	0.00417	CcSEcCtD
Benzatropine—Hypersensitivity—Vinblastine—lung cancer	0.00114	0.00405	CcSEcCtD
Benzatropine—Decreased appetite—Vinorelbine—lung cancer	0.00111	0.00397	CcSEcCtD
Benzatropine—Vision blurred—Cisplatin—lung cancer	0.00111	0.00395	CcSEcCtD
Benzatropine—Hypersensitivity—Topotecan—lung cancer	0.0011	0.00393	CcSEcCtD
Benzatropine—Constipation—Vinorelbine—lung cancer	0.0011	0.0039	CcSEcCtD
Benzatropine—Cerebrovascular accident—Methotrexate—lung cancer	0.00109	0.0039	CcSEcCtD
Benzatropine—Confusional state—Irinotecan—lung cancer	0.00107	0.0038	CcSEcCtD
Benzatropine—Feeling abnormal—Vinorelbine—lung cancer	0.00106	0.00376	CcSEcCtD
Benzatropine—Tension—Paclitaxel—lung cancer	0.00104	0.00369	CcSEcCtD
Benzatropine—Nervousness—Paclitaxel—lung cancer	0.00103	0.00365	CcSEcCtD
Benzatropine—Hypoaesthesia—Docetaxel—lung cancer	0.00102	0.00365	CcSEcCtD
Benzatropine—Body temperature increased—Vinorelbine—lung cancer	0.00101	0.00361	CcSEcCtD
Benzatropine—Vision blurred—Paclitaxel—lung cancer	0.000995	0.00355	CcSEcCtD
Benzatropine—Vomiting—Vinblastine—lung cancer	0.00098	0.00349	CcSEcCtD
Benzatropine—Vomiting—Topotecan—lung cancer	0.000952	0.00339	CcSEcCtD
Benzatropine—Cerebrovascular accident—Doxorubicin—lung cancer	0.000946	0.00337	CcSEcCtD
Benzatropine—Rash—Topotecan—lung cancer	0.000944	0.00337	CcSEcCtD
Benzatropine—Hypersensitivity—Vinorelbine—lung cancer	0.000944	0.00336	CcSEcCtD
Benzatropine—Dermatitis—Topotecan—lung cancer	0.000943	0.00336	CcSEcCtD
Benzatropine—Vomiting—Erlotinib—lung cancer	0.000942	0.00336	CcSEcCtD
Benzatropine—Tachycardia—Cisplatin—lung cancer	0.000936	0.00334	CcSEcCtD
Benzatropine—Rash—Erlotinib—lung cancer	0.000934	0.00333	CcSEcCtD
Benzatropine—Dermatitis—Erlotinib—lung cancer	0.000933	0.00333	CcSEcCtD
Benzatropine—Decreased appetite—Irinotecan—lung cancer	0.000918	0.00327	CcSEcCtD
Benzatropine—Nausea—Vinblastine—lung cancer	0.000916	0.00326	CcSEcCtD
Benzatropine—Constipation—Irinotecan—lung cancer	0.000903	0.00322	CcSEcCtD
Benzatropine—Decreased appetite—Gemcitabine—lung cancer	0.000895	0.00319	CcSEcCtD
Benzatropine—Nausea—Topotecan—lung cancer	0.000889	0.00317	CcSEcCtD
Benzatropine—Confusional state—Etoposide—lung cancer	0.000886	0.00316	CcSEcCtD
Benzatropine—Constipation—Gemcitabine—lung cancer	0.00088	0.00314	CcSEcCtD
Benzatropine—Nausea—Erlotinib—lung cancer	0.00088	0.00314	CcSEcCtD
Benzatropine—Dry mouth—Paclitaxel—lung cancer	0.000879	0.00313	CcSEcCtD
Benzatropine—Feeling abnormal—Irinotecan—lung cancer	0.000871	0.0031	CcSEcCtD
Benzatropine—Confusional state—Paclitaxel—lung cancer	0.000869	0.0031	CcSEcCtD
Benzatropine—Dysuria—Methotrexate—lung cancer	0.000866	0.00309	CcSEcCtD
Benzatropine—Tachycardia—Etoposide—lung cancer	0.000858	0.00306	CcSEcCtD
Benzatropine—Feeling abnormal—Gemcitabine—lung cancer	0.000848	0.00302	CcSEcCtD
Benzatropine—Cinnarizine—CYP2A6—lung cancer	0.000847	0.0629	CrCbGaD
Benzatropine—Tachycardia—Paclitaxel—lung cancer	0.000841	0.003	CcSEcCtD
Benzatropine—Body temperature increased—Irinotecan—lung cancer	0.000835	0.00298	CcSEcCtD
Benzatropine—Decreased appetite—Cisplatin—lung cancer	0.000834	0.00297	CcSEcCtD
Benzatropine—Vomiting—Vinorelbine—lung cancer	0.000814	0.0029	CcSEcCtD
Benzatropine—Body temperature increased—Gemcitabine—lung cancer	0.000814	0.0029	CcSEcCtD
Benzatropine—Rash—Vinorelbine—lung cancer	0.000808	0.00288	CcSEcCtD
Benzatropine—Dermatitis—Vinorelbine—lung cancer	0.000807	0.00288	CcSEcCtD
Benzatropine—Dysphagia—Doxorubicin—lung cancer	0.000802	0.00286	CcSEcCtD
Benzatropine—Feeling abnormal—Cisplatin—lung cancer	0.00079	0.00282	CcSEcCtD
Benzatropine—Hypersensitivity—Irinotecan—lung cancer	0.000778	0.00277	CcSEcCtD
Benzatropine—Decreased appetite—Etoposide—lung cancer	0.000764	0.00272	CcSEcCtD
Benzatropine—Nausea—Vinorelbine—lung cancer	0.000761	0.00271	CcSEcCtD
Benzatropine—Body temperature increased—Cisplatin—lung cancer	0.000758	0.0027	CcSEcCtD
Benzatropine—Constipation—Etoposide—lung cancer	0.000751	0.00268	CcSEcCtD
Benzatropine—Dysuria—Doxorubicin—lung cancer	0.000749	0.00267	CcSEcCtD
Benzatropine—Decreased appetite—Paclitaxel—lung cancer	0.000749	0.00267	CcSEcCtD
Benzatropine—Dry mouth—Docetaxel—lung cancer	0.000745	0.00266	CcSEcCtD
Benzatropine—Constipation—Paclitaxel—lung cancer	0.000737	0.00263	CcSEcCtD
Benzatropine—Confusional state—Docetaxel—lung cancer	0.000736	0.00262	CcSEcCtD
Benzatropine—Feeling abnormal—Etoposide—lung cancer	0.000724	0.00258	CcSEcCtD
Benzatropine—Tachycardia—Docetaxel—lung cancer	0.000713	0.00254	CcSEcCtD
Benzatropine—Feeling abnormal—Paclitaxel—lung cancer	0.00071	0.00253	CcSEcCtD
Benzatropine—Hypersensitivity—Cisplatin—lung cancer	0.000707	0.00252	CcSEcCtD
Benzatropine—Reboxetine—ABCB1—lung cancer	0.000696	0.0517	CrCbGaD
Benzatropine—Body temperature increased—Etoposide—lung cancer	0.000695	0.00248	CcSEcCtD
Benzatropine—Body temperature increased—Paclitaxel—lung cancer	0.000681	0.00243	CcSEcCtD
Benzatropine—Vomiting—Irinotecan—lung cancer	0.000672	0.00239	CcSEcCtD
Benzatropine—Rash—Irinotecan—lung cancer	0.000666	0.00237	CcSEcCtD
Benzatropine—Dermatitis—Irinotecan—lung cancer	0.000666	0.00237	CcSEcCtD
Benzatropine—Vomiting—Gemcitabine—lung cancer	0.000654	0.00233	CcSEcCtD
Benzatropine—Rash—Gemcitabine—lung cancer	0.000649	0.00231	CcSEcCtD
Benzatropine—Dermatitis—Gemcitabine—lung cancer	0.000648	0.00231	CcSEcCtD
Benzatropine—Hypersensitivity—Etoposide—lung cancer	0.000647	0.00231	CcSEcCtD
Benzatropine—Hypoaesthesia—Doxorubicin—lung cancer	0.000638	0.00228	CcSEcCtD
Benzatropine—Decreased appetite—Docetaxel—lung cancer	0.000635	0.00226	CcSEcCtD
Benzatropine—Hypersensitivity—Paclitaxel—lung cancer	0.000635	0.00226	CcSEcCtD
Benzatropine—Nausea—Irinotecan—lung cancer	0.000628	0.00224	CcSEcCtD
Benzatropine—Constipation—Docetaxel—lung cancer	0.000625	0.00223	CcSEcCtD
Benzatropine—Nausea—Gemcitabine—lung cancer	0.000611	0.00218	CcSEcCtD
Benzatropine—Vomiting—Cisplatin—lung cancer	0.00061	0.00217	CcSEcCtD
Benzatropine—Vision blurred—Methotrexate—lung cancer	0.000608	0.00217	CcSEcCtD
Benzatropine—Rash—Cisplatin—lung cancer	0.000605	0.00216	CcSEcCtD
Benzatropine—Dermatitis—Cisplatin—lung cancer	0.000604	0.00215	CcSEcCtD
Benzatropine—Feeling abnormal—Docetaxel—lung cancer	0.000602	0.00215	CcSEcCtD
Benzatropine—Cinnarizine—CYP1A1—lung cancer	0.000593	0.044	CrCbGaD
Benzatropine—Body temperature increased—Docetaxel—lung cancer	0.000577	0.00206	CcSEcCtD
Benzatropine—Nausea—Cisplatin—lung cancer	0.00057	0.00203	CcSEcCtD
Benzatropine—Vomiting—Etoposide—lung cancer	0.000559	0.00199	CcSEcCtD
Benzatropine—Rash—Etoposide—lung cancer	0.000554	0.00197	CcSEcCtD
Benzatropine—Dermatitis—Etoposide—lung cancer	0.000554	0.00197	CcSEcCtD
Benzatropine—Tension—Doxorubicin—lung cancer	0.000548	0.00195	CcSEcCtD
Benzatropine—Vomiting—Paclitaxel—lung cancer	0.000548	0.00195	CcSEcCtD
Benzatropine—Rash—Paclitaxel—lung cancer	0.000543	0.00194	CcSEcCtD
Benzatropine—Dermatitis—Paclitaxel—lung cancer	0.000543	0.00193	CcSEcCtD
Benzatropine—Nervousness—Doxorubicin—lung cancer	0.000542	0.00193	CcSEcCtD
Benzatropine—Hypersensitivity—Docetaxel—lung cancer	0.000538	0.00192	CcSEcCtD
Benzatropine—Confusional state—Methotrexate—lung cancer	0.000531	0.00189	CcSEcCtD
Benzatropine—Vision blurred—Doxorubicin—lung cancer	0.000526	0.00188	CcSEcCtD
Benzatropine—Nausea—Etoposide—lung cancer	0.000522	0.00186	CcSEcCtD
Benzatropine—Nausea—Paclitaxel—lung cancer	0.000512	0.00182	CcSEcCtD
Benzatropine—Dry mouth—Doxorubicin—lung cancer	0.000465	0.00166	CcSEcCtD
Benzatropine—Vomiting—Docetaxel—lung cancer	0.000464	0.00166	CcSEcCtD
Benzatropine—Rash—Docetaxel—lung cancer	0.00046	0.00164	CcSEcCtD
Benzatropine—Dermatitis—Docetaxel—lung cancer	0.00046	0.00164	CcSEcCtD
Benzatropine—Confusional state—Doxorubicin—lung cancer	0.00046	0.00164	CcSEcCtD
Benzatropine—Decreased appetite—Methotrexate—lung cancer	0.000458	0.00163	CcSEcCtD
Benzatropine—Tachycardia—Doxorubicin—lung cancer	0.000445	0.00159	CcSEcCtD
Benzatropine—Nausea—Docetaxel—lung cancer	0.000434	0.00155	CcSEcCtD
Benzatropine—Feeling abnormal—Methotrexate—lung cancer	0.000434	0.00155	CcSEcCtD
Benzatropine—Body temperature increased—Methotrexate—lung cancer	0.000416	0.00148	CcSEcCtD
Benzatropine—Orphenadrine—CYP2E1—lung cancer	0.000408	0.0303	CrCbGaD
Benzatropine—Decreased appetite—Doxorubicin—lung cancer	0.000396	0.00141	CcSEcCtD
Benzatropine—Constipation—Doxorubicin—lung cancer	0.00039	0.00139	CcSEcCtD
Benzatropine—Hypersensitivity—Methotrexate—lung cancer	0.000388	0.00138	CcSEcCtD
Benzatropine—Feeling abnormal—Doxorubicin—lung cancer	0.000376	0.00134	CcSEcCtD
Benzatropine—Body temperature increased—Doxorubicin—lung cancer	0.00036	0.00128	CcSEcCtD
Benzatropine—Hypersensitivity—Doxorubicin—lung cancer	0.000336	0.0012	CcSEcCtD
Benzatropine—Vomiting—Methotrexate—lung cancer	0.000335	0.00119	CcSEcCtD
Benzatropine—Rash—Methotrexate—lung cancer	0.000332	0.00118	CcSEcCtD
Benzatropine—Dermatitis—Methotrexate—lung cancer	0.000332	0.00118	CcSEcCtD
Benzatropine—Fentanyl—ABCB1—lung cancer	0.000319	0.0237	CrCbGaD
Benzatropine—Nausea—Methotrexate—lung cancer	0.000313	0.00111	CcSEcCtD
Benzatropine—Vomiting—Doxorubicin—lung cancer	0.00029	0.00103	CcSEcCtD
Benzatropine—Rash—Doxorubicin—lung cancer	0.000287	0.00102	CcSEcCtD
Benzatropine—Dermatitis—Doxorubicin—lung cancer	0.000287	0.00102	CcSEcCtD
Benzatropine—Nausea—Doxorubicin—lung cancer	0.000271	0.000965	CcSEcCtD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.34e-05	0.000203	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FOXO3—lung cancer	3.34e-05	0.000203	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTT1—lung cancer	3.34e-05	0.000203	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—MAP2K1—lung cancer	3.33e-05	0.000202	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—MAP2K1—lung cancer	3.32e-05	0.000202	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—PIK3CD—lung cancer	3.3e-05	0.000201	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GCLC—lung cancer	3.3e-05	0.0002	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CYP2A6—lung cancer	3.3e-05	0.0002	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—PIK3CD—lung cancer	3.29e-05	0.0002	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—MAP2K1—lung cancer	3.27e-05	0.000199	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—PIK3CD—lung cancer	3.25e-05	0.000198	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—AVP—lung cancer	3.18e-05	0.000193	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—PIK3CB—lung cancer	3.17e-05	0.000193	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—AVP—lung cancer	3.17e-05	0.000193	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—PIK3CB—lung cancer	3.16e-05	0.000192	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—AVP—lung cancer	3.13e-05	0.00019	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ENO1—lung cancer	3.13e-05	0.00019	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—PIK3CB—lung cancer	3.12e-05	0.00019	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IGF1R—lung cancer	3.06e-05	0.000186	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IGF1R—lung cancer	3.05e-05	0.000185	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CYP2E1—lung cancer	3.05e-05	0.000185	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—CXCL8—lung cancer	3.05e-05	0.000185	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—CXCL8—lung cancer	3.04e-05	0.000185	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—NQO1—lung cancer	3.01e-05	0.000183	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IGF1R—lung cancer	3.01e-05	0.000183	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HES1—lung cancer	3.01e-05	0.000183	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—CXCL8—lung cancer	3e-05	0.000182	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HES1—lung cancer	3e-05	0.000182	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HES1—lung cancer	2.96e-05	0.00018	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.95e-05	0.000179	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—RAF1—lung cancer	2.95e-05	0.000179	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—RAF1—lung cancer	2.94e-05	0.000179	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.92e-05	0.000178	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—IL2—lung cancer	2.91e-05	0.000177	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—IL2—lung cancer	2.9e-05	0.000176	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—RAF1—lung cancer	2.9e-05	0.000176	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—PIK3CB—lung cancer	2.88e-05	0.000175	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—PIK3CB—lung cancer	2.87e-05	0.000175	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—IL2—lung cancer	2.87e-05	0.000174	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	2.83e-05	0.000172	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CYP2E1—lung cancer	2.8e-05	0.00017	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—NQO1—lung cancer	2.77e-05	0.000169	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—CXCL8—lung cancer	2.77e-05	0.000168	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—CXCL8—lung cancer	2.76e-05	0.000168	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ERBB3—lung cancer	2.75e-05	0.000167	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ERBB3—lung cancer	2.74e-05	0.000167	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—CXCL8—lung cancer	2.72e-05	0.000166	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—STK11—lung cancer	2.72e-05	0.000165	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ERBB3—lung cancer	2.71e-05	0.000164	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—IL2—lung cancer	2.65e-05	0.000161	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—IL2—lung cancer	2.64e-05	0.00016	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TERT—lung cancer	2.64e-05	0.00016	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TERT—lung cancer	2.63e-05	0.00016	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—IL2—lung cancer	2.6e-05	0.000158	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TERT—lung cancer	2.59e-05	0.000158	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FGFR1—lung cancer	2.56e-05	0.000156	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FGFR1—lung cancer	2.55e-05	0.000155	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.55e-05	0.000155	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HIF1A—lung cancer	2.52e-05	0.000153	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FGFR1—lung cancer	2.52e-05	0.000153	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTP1—lung cancer	2.51e-05	0.000153	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HIF1A—lung cancer	2.51e-05	0.000153	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—STK11—lung cancer	2.5e-05	0.000152	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HIF1A—lung cancer	2.48e-05	0.000151	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CAT—lung cancer	2.45e-05	0.000149	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—APOA1—lung cancer	2.43e-05	0.000148	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.43e-05	0.000148	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—APOA1—lung cancer	2.42e-05	0.000147	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KDR—lung cancer	2.41e-05	0.000147	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KDR—lung cancer	2.4e-05	0.000146	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—APOA1—lung cancer	2.39e-05	0.000145	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ABCB1—lung cancer	2.38e-05	0.000145	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KDR—lung cancer	2.37e-05	0.000144	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—TYMS—lung cancer	2.34e-05	0.000142	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTP1—lung cancer	2.31e-05	0.000141	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTM1—lung cancer	2.31e-05	0.00014	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CAT—lung cancer	2.25e-05	0.000137	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—APC—lung cancer	2.22e-05	0.000135	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KIT—lung cancer	2.22e-05	0.000135	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CG—lung cancer	2.22e-05	0.000135	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—NRAS—lung cancer	2.22e-05	0.000135	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KIT—lung cancer	2.21e-05	0.000135	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CG—lung cancer	2.21e-05	0.000135	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—APC—lung cancer	2.21e-05	0.000135	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—NRAS—lung cancer	2.21e-05	0.000135	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—EGF—lung cancer	2.19e-05	0.000133	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CYP1A1—lung cancer	2.19e-05	0.000133	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ABCB1—lung cancer	2.19e-05	0.000133	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—EGF—lung cancer	2.19e-05	0.000133	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—APC—lung cancer	2.18e-05	0.000133	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CG—lung cancer	2.18e-05	0.000133	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KIT—lung cancer	2.18e-05	0.000133	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—NRAS—lung cancer	2.18e-05	0.000133	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ERCC2—lung cancer	2.17e-05	0.000132	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—EGF—lung cancer	2.16e-05	0.000131	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—TYMS—lung cancer	2.15e-05	0.000131	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—MAPK3—lung cancer	2.13e-05	0.000129	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTM1—lung cancer	2.12e-05	0.000129	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—MAPK3—lung cancer	2.12e-05	0.000129	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—POMC—lung cancer	2.11e-05	0.000128	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—POMC—lung cancer	2.11e-05	0.000128	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—MAPK3—lung cancer	2.09e-05	0.000127	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—BRAF—lung cancer	2.09e-05	0.000127	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—BRAF—lung cancer	2.08e-05	0.000126	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—POMC—lung cancer	2.08e-05	0.000126	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL6R—lung cancer	2.06e-05	0.000125	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CREBBP—lung cancer	2.06e-05	0.000125	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL6R—lung cancer	2.06e-05	0.000125	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—BRAF—lung cancer	2.05e-05	0.000125	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CREBBP—lung cancer	2.05e-05	0.000125	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL6R—lung cancer	2.03e-05	0.000123	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CREBBP—lung cancer	2.03e-05	0.000123	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—EGFR—lung cancer	2.02e-05	0.000123	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—EGFR—lung cancer	2.02e-05	0.000123	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CYP1A1—lung cancer	2.01e-05	0.000122	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ERCC2—lung cancer	2e-05	0.000121	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—EGFR—lung cancer	1.99e-05	0.000121	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MAP2K1—lung cancer	1.96e-05	0.000119	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MAP2K1—lung cancer	1.96e-05	0.000119	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CD—lung cancer	1.95e-05	0.000119	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CD—lung cancer	1.95e-05	0.000118	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	1.93e-05	0.000118	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MAP2K1—lung cancer	1.93e-05	0.000118	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	1.93e-05	0.000117	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CD—lung cancer	1.92e-05	0.000117	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—KRAS—lung cancer	1.91e-05	0.000116	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—KRAS—lung cancer	1.9e-05	0.000116	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	1.9e-05	0.000116	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—KRAS—lung cancer	1.88e-05	0.000114	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—APOA1—lung cancer	1.88e-05	0.000114	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.8e-05	0.000109	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	1.76e-05	0.000107	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	1.75e-05	0.000106	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MDM2—lung cancer	1.75e-05	0.000106	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MDM2—lung cancer	1.74e-05	0.000106	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—RAF1—lung cancer	1.74e-05	0.000106	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—RAF1—lung cancer	1.74e-05	0.000106	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—APOA1—lung cancer	1.73e-05	0.000105	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	1.73e-05	0.000105	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ERBB2—lung cancer	1.72e-05	0.000105	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MDM2—lung cancer	1.72e-05	0.000105	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ERBB2—lung cancer	1.72e-05	0.000104	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CG—lung cancer	1.72e-05	0.000104	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—RAF1—lung cancer	1.71e-05	0.000104	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CB—lung cancer	1.7e-05	0.000103	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MTOR—lung cancer	1.7e-05	0.000103	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ERBB2—lung cancer	1.7e-05	0.000103	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MTOR—lung cancer	1.7e-05	0.000103	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CB—lung cancer	1.7e-05	0.000103	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MTOR—lung cancer	1.67e-05	0.000102	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CB—lung cancer	1.67e-05	0.000102	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CXCL8—lung cancer	1.64e-05	9.94e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—POMC—lung cancer	1.63e-05	9.92e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CXCL8—lung cancer	1.63e-05	9.91e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—HRAS—lung cancer	1.62e-05	9.87e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—HRAS—lung cancer	1.62e-05	9.84e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CXCL8—lung cancer	1.61e-05	9.78e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—HRAS—lung cancer	1.6e-05	9.72e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CREBBP—lung cancer	1.59e-05	9.67e-05	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—AKT1—lung cancer	1.58e-05	9.6e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CG—lung cancer	1.58e-05	9.59e-05	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—AKT1—lung cancer	1.57e-05	9.57e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CASP3—lung cancer	1.56e-05	9.51e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL2—lung cancer	1.56e-05	9.5e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CASP3—lung cancer	1.56e-05	9.48e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL2—lung cancer	1.56e-05	9.47e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—IL6—lung cancer	1.55e-05	9.45e-05	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—AKT1—lung cancer	1.55e-05	9.45e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—IL6—lung cancer	1.55e-05	9.42e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CASP3—lung cancer	1.54e-05	9.36e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL2—lung cancer	1.54e-05	9.35e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—IL6—lung cancer	1.53e-05	9.3e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CCND1—lung cancer	1.52e-05	9.26e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—JUN—lung cancer	1.52e-05	9.24e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CCND1—lung cancer	1.52e-05	9.23e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—JUN—lung cancer	1.52e-05	9.21e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CD—lung cancer	1.51e-05	9.17e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—POMC—lung cancer	1.5e-05	9.13e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CCND1—lung cancer	1.5e-05	9.11e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—JUN—lung cancer	1.5e-05	9.09e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ALB—lung cancer	1.49e-05	9.05e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MMP9—lung cancer	1.48e-05	8.99e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MMP9—lung cancer	1.47e-05	8.96e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CDKN1A—lung cancer	1.47e-05	8.96e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PTEN—lung cancer	1.47e-05	8.94e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CDKN1A—lung cancer	1.47e-05	8.93e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PTEN—lung cancer	1.47e-05	8.91e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CREBBP—lung cancer	1.46e-05	8.89e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MMP9—lung cancer	1.46e-05	8.84e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CDKN1A—lung cancer	1.45e-05	8.81e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PTEN—lung cancer	1.45e-05	8.79e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—AKT1—lung cancer	1.43e-05	8.72e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—AKT1—lung cancer	1.43e-05	8.69e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—AKT1—lung cancer	1.41e-05	8.58e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—EP300—lung cancer	1.4e-05	8.52e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—EP300—lung cancer	1.4e-05	8.5e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CD—lung cancer	1.39e-05	8.43e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—EP300—lung cancer	1.38e-05	8.39e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ALB—lung cancer	1.37e-05	8.32e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—SRC—lung cancer	1.36e-05	8.29e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SRC—lung cancer	1.36e-05	8.26e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SRC—lung cancer	1.34e-05	8.15e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—VEGFA—lung cancer	1.33e-05	8.07e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—VEGFA—lung cancer	1.32e-05	8.05e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—STAT3—lung cancer	1.31e-05	7.99e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CB—lung cancer	1.31e-05	7.99e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—NRAS—lung cancer	1.31e-05	7.97e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—STAT3—lung cancer	1.31e-05	7.97e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—NRAS—lung cancer	1.31e-05	7.95e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.31e-05	7.94e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PTGS2—lung cancer	1.3e-05	7.92e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—STAT3—lung cancer	1.29e-05	7.86e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—NRAS—lung cancer	1.29e-05	7.85e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MAPK3—lung cancer	1.26e-05	7.64e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MAPK3—lung cancer	1.25e-05	7.61e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.24e-05	7.51e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MYC—lung cancer	1.22e-05	7.43e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MYC—lung cancer	1.22e-05	7.4e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.21e-05	7.35e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MYC—lung cancer	1.2e-05	7.31e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PTGS2—lung cancer	1.2e-05	7.28e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—EGFR—lung cancer	1.2e-05	7.26e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—EGFR—lung cancer	1.19e-05	7.24e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—EGFR—lung cancer	1.18e-05	7.15e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PTEN—lung cancer	1.14e-05	6.9e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KRAS—lung cancer	1.13e-05	6.86e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KRAS—lung cancer	1.13e-05	6.84e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KRAS—lung cancer	1.11e-05	6.75e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—EP300—lung cancer	1.08e-05	6.58e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PTEN—lung cancer	1.04e-05	6.35e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CA—lung cancer	1.04e-05	6.3e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CA—lung cancer	1.03e-05	6.28e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.02e-05	6.2e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TP53—lung cancer	1e-05	6.1e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TP53—lung cancer	1e-05	6.08e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—EP300—lung cancer	9.96e-06	6.06e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TP53—lung cancer	9.87e-06	6e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HRAS—lung cancer	9.6e-06	5.83e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HRAS—lung cancer	9.57e-06	5.81e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HRAS—lung cancer	9.44e-06	5.74e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL6—lung cancer	9.18e-06	5.58e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL6—lung cancer	9.16e-06	5.56e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL6—lung cancer	9.04e-06	5.49e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—AKT1—lung cancer	8.47e-06	5.15e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—AKT1—lung cancer	8.45e-06	5.13e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—AKT1—lung cancer	8.34e-06	5.07e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CA—lung cancer	8.01e-06	4.87e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CA—lung cancer	7.37e-06	4.48e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—AKT1—lung cancer	6.55e-06	3.98e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—AKT1—lung cancer	6.02e-06	3.66e-05	CbGpPWpGaD
